Autocrine positive feedback of tumor necrosis factor from activated microglia proposed to be of widespread relevance in chronic neurological disease
Open Access
- 26 September 2023
- journal article
- review article
- Published by Wiley in Pharmacology Research & Perspectives
- Vol. 11 (5) , e01136
Abstract
Over a decade's experience of post‐stroke rehabilitation by administering the specific anti‐TNF biological, etanercept, by the novel perispinal route, is consistent with a wide range of chronically diminished neurological function having been caused by persistent excessive cerebral levels of TNF. We propose that this TNF persistence, and cerebral disease chronicity, largely arises from a positive autocrine feedback loop of this cytokine, allowing the persistence of microglial activation caused by the excess TNF that these cells produce. It appears that many of these observations have never been exploited to construct a broad understanding and treatment of certain chronic, yet reversible, neurological illnesses. We propose that this treatment allows these chronically activated microglia to revert to their normal quiescent state, rather than simply neutralizing the direct harmful effects of this cytokine after its release from microglia. Logically, this also applies to the chronic cerebral aspects of various other neurological conditions characterized by activated microglia. These include long COVID, Lyme disease, post‐stroke syndromes, traumatic brain injury, chronic traumatic encephalopathy, post‐chemotherapy, post‐irradiation cerebral dysfunction, cerebral palsy, fetal alcohol syndrome, hepatic encephalopathy, the antinociceptive state of morphine tolerance, and neurogenic pain. In addition, certain psychiatric states, in isolation or as sequelae of infectious diseases such as Lyme disease and long COVID, are candidates for being understood through this approach and treated accordingly. Perispinal etanercept provides the prospect of being able to treat various chronic central nervous system illnesses, whether they are of infectious or non‐infectious origin, through reversing excess TNF generation by microglia.Keywords
This publication has 127 references indexed in Scilit:
- Inflammatory Cascades Driven by Tumor Necrosis Factor-Alpha Play a Major Role in the Progression of Acute Liver Failure and Its Neurological ComplicationsPLOS ONE, 2012
- The Instrumented Fetal Sheep as a Model of Cerebral White Matter Injury in the Premature InfantNeurotherapeutics, 2012
- Tumor necrosis factor-alpha regulates the Hypocretin system via mRNA degradation and ubiquitinationBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Toll‐like receptor 4 in CNS pathologiesJournal of Neurochemistry, 2010
- TNF-α and neuropathic pain - a reviewJournal of Neuroinflammation, 2010
- Pathological and protective roles of glia in chronic painNature Reviews Neuroscience, 2009
- Tumor Necrosis Factor-α Potentiates Intraneuronal Ca2+ Signaling via Regulation of the Inositol 1,4,5-Trisphosphate ReceptorJournal of Biological Chemistry, 2008
- Lyme warsBMJ, 2007
- Systemic LPS causes chronic neuroinflammation and progressive neurodegenerationGlia, 2007
- THE FUNCTION OF THE VERTEBRAL VEINS AND THEIR ROLE IN THE SPREAD OF METASTASESAnnals of Surgery, 1940